releases: https://www.alexander.senate.gov/public/index.cfm/pressreleases?ContentRecord_id=6E0592D8-B84E-4090-ABD1-776C23D861B2
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://www.alexander.senate.gov/public/index.cfm/pressreleases?ContentRecord_id=6E0592D8-B84E-4090-ABD1-776C23D861B2 | Alexander Statement on FDA Regenerative Medicine Guidance | 2017-11-16 | 2017 | 2017-11 | Republican | House | TN | Lamar Alexander | A000360 | www.alexander.senate.gov | legacy | WASHINGTON, Nov. 16, 2017 – Senate health committee Chairman Lamar Alexander (R-Tenn.) today made the following statement about new Food and Drug Administration guidance on regenerative medicine: “I am glad Commissioner Gottlieb is implementing the 21st Century Cures Act in such a way that Americans can access the near-miracles regenerative medicine can provide while ensuring bad actors don’t take advantage of the hope and promise in this field to harm or defraud patients looking for help.” | 1 | 2026-03-30T12:14:52Z | 2026-03-30T12:14:52Z |